Carbapenemase-producing Klebsiella pneumoniae intra-abdominal infection successfully treated with ceftazidime/avibactam plus tigecycline
- Resource Type
- Authors
- Raquel Duro; Nuno Rocha-Pereira; Mariana Guedes; Isabel A. Abreu; Telma Fonseca
- Source
- IDCases, Vol 20, Iss, Pp e00745-(2020)
IDCases
- Subject
- 0301 basic medicine
medicine.medical_specialty
Klebsiella pneumoniae
Abdominal Hernia
Avibactam
030106 microbiology
Ceftazidime
Infectious and parasitic diseases
RC109-216
Tigecycline
Carbapenemase-producing Klebsiella pneumoniae
Article
03 medical and health sciences
chemistry.chemical_compound
Intra-abdominal infection
0302 clinical medicine
Ceftazidime/avibactam
Internal medicine
medicine
030212 general & internal medicine
Intra-Abdominal Infection
biology
business.industry
Carbapenemase producing
biology.organism_classification
Infectious Diseases
chemistry
business
medicine.drug
- Language
- ISSN
- 2214-2509
Ceftazidime/avibactam combines ceftazidime with a new beta-lactam that successfully that inhibits Amber Class A and D carbapenemases. We report a clinical case of a 61 year-old man with a carbapenemase-producing Klebsiella pneumoniae intra-abdominal infection after an elective abdominal hernia repair. The infection was successfully managed with multiple abdominal surgeries, drainage and combined antibiotic therapy with ceftazidime/avibactam plus tigecycline.